ISSN: 2329-8731
+44 1300 500008
Perspective - (2024)Volume 12, Issue 3
Graves' disease is an autoimmune disorder that results in the overproduction of thyroid hormones (hyperthyroidism). It is the most common cause of hyperthyroidism and affects various systems in the body, leading to a range of symptoms and complications. Named after the Irish doctor Robert Graves, who first described the condition in the 1830s, Graves' disease primarily impacts the thyroid gland but can also affect the eyes and skin.
Causes and risk factors
Graves' disease is caused by an abnormal immune response in which the body's immune system mistakenly attacks the thyroid gland. The immune system produces antibodies known as Thyroid-Stimulating Immunoglobulins (TSIs) that bind to thyroid cells, stimulating the gland to produce excess thyroid hormones. This hormonal imbalance affects metabolism and other bodily functions.
Symptoms
The symptoms of Graves' disease can vary widely and may develop gradually or suddenly. Common symptoms include.
Hyperthyroidism symptoms: Weight loss despite normal eating habits, increased appetite, rapid or irregular heartbeat (palpitations), nervousness or irritability, tremors, sweating, heat intolerance, and frequent bowel movements.
Graves' ophthalmopathy: Also known as thyroid eye disease, this condition affects about 30% of people with Graves' disease. Symptoms include bulging eyes (exophthalmos), eye pain, double vision, light sensitivity, and vision problems. A rare condition that causes red, swollen skin, often on the shins and tops of the feet, known as pretibial myxoedema.
Diagnosis
Diagnosing Graves' disease involves several steps.
Blood tests: Tests measure levels of thyroid hormones (T3 and T4) and Thyroid-Stimulating Hormone (TSH). In Graves' disease, TSH levels are usually low, while T3 and T4 levels are high. The presence of TSIs can also confirm the diagnosis.
Radioactive iodine uptake test: This test measures the thyroid gland's ability to absorb iodine. A high uptake indicates an overactive thyroid, which is common in Graves' disease. Imaging of the thyroid can help visualize the gland's activity and structure.
Treatment
Treatment for Graves' disease aims to reduce the production of thyroid hormones and alleviate symptoms.
Antithyroid medications: Drugs such as methimazole and PropylThioUracil (PTU) reduce thyroid hormone production. These medications are often the first line of treatment and can control symptoms within weeks to months.
Radioactive iodine therapy: Radioactive iodine is taken orally and absorbed by the thyroid gland, where it destroys overactive thyroid cells. This treatment can lead to a reduction in hormone levels but may result in hypothyroidism, requiring lifelong thyroid hormone replacement therapy.
Surgery (Thyroidectomy): Partial or total removal of the thyroid gland may be necessary in severe cases or when other treatments are not effective. Surgery can also lead to hypothyroidism, requiring hormone replacement.
Beta-blockers: These medications do not treat the underlying thyroid problem but can help manage symptoms such as rapid heart rate, tremors, and anxiety. For Graves' ophthalmopathy, options include corticosteroids, radiation therapy, or surgery to relieve eye pressure and correct vision issues.
Lifestyle and self-care
Regular follow-up appointments with a healthcare provider to monitor thyroid hormone levels and adjust treatments as necessary. A balanced diet rich in nutrients supports overall health. Patients should avoid excessive iodine intake, which can exacerbate symptoms. Techniques such as yoga, meditation, and other relaxation methods can help manage stress, which may trigger or worsen symptoms.
Citation: Kajita S (2024) Early Detection and Treatment of Gravesâ?? Disease: A Symptom-Based Approach. Infect Dis Preve Med. 12:363.
Received: 03-May-2024, Manuscript No. jadpr-24-31674; Editor assigned: 06-May-2024, Pre QC No. jadpr-24-31674 (PQ); Reviewed: 20-May-2024, QC No. jadpr-24-31674; Revised: 27-May-2024, Manuscript No. jadpr-24-31674 (R); Published: 04-Jun-2024 , DOI: 10.35841/2329-8731.24.12.363
Copyright: © 2024 Kajita S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.